FDA Moves To Implement New GMP Policies

November 2, 2004
Jill Wechsler
Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Pharmaceutical Technology, Pharmaceutical Technology-11-02-2004, Volume 28, Issue 11

Phase II of FDA's GMP modernization plan may involve revising regulations to fit new policies and inspection and review programs.